Key result
Higher DETERMINE score at discharge linked to ~9% higher odds of large infarct size per point.
Why the study?
The DETERMINE score was proposed to estimate myocardial scar in ischaemic cardiomyopathy, but its usefulness for assessing myocardial infarct size and microvascular obstruction in STEMI was unevaluated.
Does the DETERMINE score estimate myocardial infarct size and microvascular obstruction in patients with STEMI revascularised by primary PCI?
Observational (n=423)
Single-blind
Does the DETERMINE score estimate myocardial infarct size and microvascular obstruction in patients with STEMI revascularised by primary PCI?
Odds Ratio: 1.09 (95% CI 1.02–1.17)
p-value: p=0.014
The DETERMINE score provides an easy and inexpensive ECG-based tool for estimating infarct severity and microvascular obstruction in STEMI patients.
May identify higher-risk STEMI patients; hypothesis-generating and requires prospective validation before clinical use.
Background Recently, a simple ECG score (DETERMINE score) has been proposed for estimating myocardial scar in patients with ischaemic cardiomyopathy. We sought to evaluate the usefulness of the DETERMINE score for the assessment of myocardial infarct size (IS) as well as microvascular obstruction (MVO), in the setting of ST-elevation myocardial infarction (STEMI). Methods This observational study enrolled 423 patients with STEMI (median age 56, 17% women), revascularised by primary percutaneous coronary intervention (PCI). For evaluation of the DETERMINE and Selvester scoring system (an established but complex ECG score for IS estimation), ECG was conducted before discharge (median: 4 (IQR 2–6) days). Cardiac magnetic resonance (CMR) was conducted within a week after infarction for determination of IS and MVO. Results Median DETERMINE score of the overall cohort was 8 points (IQR 5–11). A higher DETERMINE score was significantly associated with a larger IS (21% vs 11% of left ventricular myocardial mass (LVMM), p<0.001) as well as larger MVO (1.2% vs 0.0% of LVMM, p<0.001). In linear and binary multivariable logistic regression analysis, the DETERMINE score remained independently associated with IS (OR 1.09, 95% CI 1.02 to 1.17, p=0.014) and MVO (OR 1.12, 95% CI 1.04 to 1.21, p=0.003), after adjustment for Selvester score and clinical indicators of IS (high-sensitivity cardiac troponin T, high-sensitivity C reactive protein, N-terminal pro-B-type natriuretic peptide, TIMI flow pre-interventional and post-interventional PCI, anterior infarct localisation). Conclusions In patients undergoing PCI for STEMI, the DETERMINE score provides an easy and inexpensive tool for appropriate estimation of infarct severity as determined by CMR.
No takes yet. Share an insight, caveat, or question.
Tiller et al. (2021) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=423). DETERMINE score vs. Selvester score and clinical indicators was evaluated on Large infarct size (>19% of left ventricular myocardial mass) (OR 1.09, 95% CI 1.02 to 1.17, p=0.014). The DETERMINE score evaluated at discharge was independently associated with a larger myocardial infarct size (OR 1.09 per point) and microvascular obstruction (OR 1.12 per point) in STEMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: